Company Revenue

The company grew in the mid-single-digits in FY 3Q26 on the strength of core spine pull-through from its enabling technology...

The company grew in the double digits for the fourth quarter of 2025, but tempered expectations for 2026 due to...

The company grew in the high single digits on a pro forma basis on the strength of Mako, shoulders and...

The company grew in the teens for the fourth quarter of 2025 as its orthopedic execution and supply chain become...

The company's orthopedics business grew in the mid-single-digits in the fourth quarter of 2025 after an up and down year....

The company grew in the mid-single-digits for the third quarter of 2025, driven by strength in U.S. hips and global...

The company grew more than 57% in the third quarter of 2025 as it added surgeon users and expanded its...

The company nearly doubled its sales quarter-over-quarter, increased its surgeon user base and reduced lead times....

The company's base business grew 7% in the third quarter of 2025, driven by U.S. spine sales and offset by...

The company grew in the low double-digits, but volume headwinds caused Treace to revise its 2025 guidance downward....